The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) is the Department of Defense’s (DoD) lead laboratory for medical biological defense research. USAMRIID has awarded a sole source contract to Life [Read more]
Health officials in Democratic Republic of Congo have reported 21 patients showing signs of hemorrhagic fever and 17 deaths in the affected area before an Ebola outbreak was confirmed today. Ground teams [Read more]
See what we’re reading this week at Global Biodefense on topics including regulation of genetically engineered livestock, chemical weapons investigators in Douma, and the latest news on rapid diagnostics. POLICY + INITIATIVES GAO asks [Read more]
See what we’re reading this week at Global Biodefense on topics including transnational biological threats, modernizing epidemiology, smallpox vaccine MVA, and drug-resistant typhoid outbreaks. POLICY + INITIATIVES NIAID research addressing biodefense and emerging and [Read more]
See what we’re reading this week at Global Biodefense on topics including early warning systems for WMDs, experimental Ebola vaccines, and the new congressional biodefense caucus. BIOPREPAREDNESS An early warning system for WMDs The [Read more]
Researchers at Texas Biomedical Research Institute in San Antonio have been awarded a $2 million dollar contract by the makers of ZMapp, Mapp Biopharmaceutical, Inc., to further test this promising new therapeutic [Read more]
The Defense Advanced Research Projects Agency (DARPA) launched the Pandemic Prevention Platform (P3) program in 2017, with the eventual goal of halting the spread of any infectious disease outbreak before it can escalate into a pandemic. [Read more]
See what we’re reading this week at Global Biodefense on topics including the dangers of horsepox synthesis, portable biodosimetry systems, and improving vector-borne pathogen surveillance. SELECT AGENTS Horsepox Synthesis: A Case of [Read more]
Prior studies of survivors of the 2014-2016 Ebola outbreak in West Africa have revealed sexual transmission of Ebola virus, and that viral RNA (Ebola virus genetic material) can persist in semen following recovery. [Read more]
The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential to cause a public health emergency and the absence of efficacious medical [Read more]
© 2018 Global Biodefense